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Abstract. Malaria is frequently diagnosed in urban Kampala, despite low transmission intensity. To evaluate the
association between recent travel out of Kampala andmalaria, we conducted amatched case–control study. Caseswere
febrile outpatients with a positive malaria test; controls were febrile outpatients with a negative test. For every two cases,
five controls were selected, matching on age. Data were collected on recent overnight travel out of Kampala (past
60 days), destination and duration of travel, and behavioral factors, including sleeping under an insecticide-treated net
(ITN) during travel. From July to August 2019, 162 cases and 405 controls were enrolled. The locations of residence of
cases and controls were similar. More controls were female (62.7% versus 46.3%, P < 0.001). Overall, 158 (27.9%)
participants reported recent overnight travel. Travelers were far more likely to be diagnosed with malaria than those who
did not travel (80.4% versus 8.6%, OR 58.9, 95% CI: 23.1–150.1, P < 0.001). Among travelers, traveling to a district not
receiving indoor residual spraying of insecticide (OR 35.0, 95%CI: 4.80–254.9, P < 0.001), no ITN use (OR 30.1, 95%CI:
6.37–142.7, P < 0.001), engaging in outdoor activities (OR 22.0, 95% CI: 3.42–141.8, P = 0.001), and age < 16 years (OR
8.36, 95% CI: 2.22–56.2, P = 0.03) were associated with increased odds of malaria. Kampala residents who traveled
overnight out of the city were at substantially higher risk of malaria than those who did not travel. For these travelers,
personal protection measures, including sleeping under an ITN when traveling, should be advocated.
INTRODUCTION
Over the past 20 years, impressive reductions in malaria
burden have been reported in across sub-Saharan Africa.1
This progress hasbeenattributed tohigh coverageof effective
interventions, including indoor residual spraying (IRS) of in-
secticides, long-lasting insecticidal bed nets, and prompt
treatment with artemisinin-based combination therapy. In-
creasing urbanization of African populations has also con-
tributed to malaria reduction.2 Despite this success, malaria
remains a global health challenge; recent evidence indicates
that the number ofmalaria cases inmanyAfrican countries has
increased, suggesting that progress on malaria control has
stalled.3 In Uganda, expansion of malaria control measures
has been associated with substantial decreases in malaria
burden in some areas,4–6 but not in all settings.7,8 Conse-
quently,malaria transmission inUganda is heterogenous,with
low risk of malaria in urban areas, highland areas, and loca-
tions where IRS has been effectively implemented, but me-
dium to high risk elsewhere in Uganda.9
In residents of malaria-endemic areas, repeated exposure
to malaria parasites results in acquisition of protective im-
munity against illness and infection.10–12 However, this ac-
quired immunity may wane if exposure to malaria parasites
reduces because of a non-endemic area or highly urbanized
environment or in the setting of intense malaria control mea-
sures.13 In Zanzibar, Tanzania, and Bioko Island, Equatorial
Guinea, travel between the island (low malaria risk following
scale-up of control measures) and the mainland (high malaria
risk) was found to be associated with malaria infection and
disease among returning residents.14–18 In Malawi, among
travelers between urban and rural areas, symptomatic malaria
was higher in participants living in urban zones who reported
spending at least one night in rural areaswithin amonth before
testing for malaria.19 In Tororo District in Eastern Uganda,
where an effective IRS campaign resulted in significant de-
clines inmalaria transmission intensity,20 travel from Tororo to
neighboring high-transmission settings was a risk factor for
malaria.21
The WHO recommends malaria chemoprophylaxis for
those traveling fromnon-endemic regions tomalaria-endemic
areas.22 However, whether this policy or other preventative
approaches would be applicable for travel within malaria-
endemic countries is less clear. In Uganda, malaria trans-
mission intensity appears to have decreased greatly in
Kampala, the urban capital, but the number of malaria cases
reported in Kampala fluctuates over time.23 To investigate the
association between overnight travel outside of Kampala and
diagnosis of clinical malaria, we conducted a case–control
study.
METHODS
Study site. The study was conducted at Naguru General
Hospital, a public hospital in Kampala. Kampala is a low
malaria transmission setting, with a reported parasite preva-
lence rate in children aged 0–59 months of 3.7% by histidine-
rich protein 2 (HRP-2) rapid diagnostic test (RDT) in
2014–2015.9 The hospital serves the Kampala metropolitan
area and provides outpatient, inpatient, and specialized care
services. Between January and September 2019, the out-
patient department served an average of 13,000 patients per
month, out of which 1,000were referred to the laboratory for a
malaria test, and an average of 110 tested positive for malaria
per month. Malaria was typically tested using RDT, with
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quantification of parasite density by microscopy for positive
RDT tests. By policy, all patients with suspected malaria were
referred to the laboratory for a malaria test before malaria
treatment was prescribed.
Study design. This was a matched case–control study.
Cases were defined as patients at least 6 months of age at-
tending the outpatient department at NaguruGeneral Hospital
with documented axillary temperature of ³ 37.5C and/or
history of fever within the last 24 hours with a positive RDT for
malaria. Controls were patients attending the same outpatient
department with documented axillary temperature of ³ 37.5C
and/or history of fever within the last 24 hours, but with a
negative malaria RDT.
Matching criteria.Controls were matched to cases by age
and time of presentation (within 1 week of a case). For every
two malaria-positive cases, five malaria-negative controls
were enrolled. Age categories matched were 0.5–5 years,
> 5–15 years, and > 15 years.
Study participant enrollment and data collection. All
patients referred to the outpatient department laboratory for
suspectedmalariawere assessed for eligibility toparticipate in
the study. Study participants were enrolled if they 1) resided in
Kampala (Kampala Central, Kawempe, Makindye, Nakawa,
and Rubaga divisions) for at least the last 3 months, 2) were at
least 0.5 years of age, 3) weighed at least 4 kg, 4) had axillary
temperature of at least 37.5C and/or a history of fever within
the last 24 hours, 5) were able to speak English or Luganda,
and 6) provided written informed consent (from parents or
guardians in children, with assent for ages 8–17 years). Pa-
tients with a positive malaria RDT result were screened as
cases and patients with a negative malaria RDT result were
screened as controls until 162 cases and 405 controls were
enrolled.
For patients who met all the eligibility criteria and provided
informed consent, a questionnaire was administered on
whether they had traveled out of Kampala within the last
60 days. If they had traveled, a detailed travel questionnaire
was administered, to capture data on destination of travel,
length of the trip, and behavioral risk factors likely to influence
exposure to mosquito bites such as staying outdoors late,
time to bed, and use of insecticide-treated nets (ITNs) during
travel.
Laboratory procedures.Malaria was diagnosed at Naguru
General Hospital by experienced laboratory technicians
with the CareStart™ RDT (Access Bio Inc., Somerset, NJ),
which assesses HRP-2, according to the manufacturer’s
instructions.
Sample size. We aimed to detect an association between
recent (within 60 days) overnight travel out of Kampala and
diagnosis of malaria. To do this, a sample size of 567 partici-
pantswas required todetect anodds ratio of at least 3.0 for the
association between overnight travel and malaria diagnosis,
given a two-sided type 1 error of 0.05 and power of 80%. We
predicted that 56%of cases and23%of controlswould report
recent overnight travel basedon data fromaperi-urban area in
Jinja, Uganda,21 and thus 162 cases and 405 controls (ratio of
2:5) were required to evaluate the association between risk
factors for malaria and overnight travel.
Ethical considerations. Ethical approvals were obtained
from the Mulago Hospital Research and Ethics Committee
(MHREC; ref. 1592), the London School of Hygiene and
TropicalMedicine Ethics Committee (LSHTM; ref. 16625), and
the Uganda National Council of Science and Technology
(UNCST; ref. SS5012). Informedconsentswere obtained from
all study participants before data collection. All study staff
were trained on procedures for maintaining confidentiality
before study activities commenced.
Statistical analysis. All data were collected by trained
study staff using a hand-held computer and transferred
weekly to a secure server. Data analyses were performed
using Stata 14 software (StataCorp, College Station, TX).
Recent overnight travel was defined as any travel outside the
geographical confinesofKampala, spendingat least onenight
away, within the previous 60 days. A 60-day threshold was
chosen to represent the period when most newly acquired
malaria infections were likely to become symptomatic, based
on the results of a prior study conducted in Uganda.21 For
study participants with a history of recent overnight travel,
destination of travel was dichotomized into districts receiving
or not receiving IRS according to U.S. President’s Malaria
Initiative VectorLink, Uganda IRS project.24 Other risk factors
that were evaluated included duration of stay at destination of
travel, reported ITN use, time to bed, place of stay, and ac-
tivities carried out during travel. Malaria cases diagnosed
within 7 days from the start of a trip were not included in the
analysis because the incubation period of Plasmodium falci-
parummalaria typically ranges from7 to14daysdependingon
the immune status of the individual.25–27 Characteristics of
study participants and individual trips were reported as pro-
portions for categorical variables and medians with interquartile
ranges for continuous variables.
The primary exposure of interest was recent overnight
travel. Conditional logistic regression analysis was used to
estimate associations (as odds ratios) between recent over-
night travel out of Kampala and diagnosis of malaria. Because
the analysis was matched on age, association between age
and the odds of malaria was not reported. For study partici-
pants with a history of recent overnight travel, unmatched
analysis of risk factors associated with malaria during travel
out of Kampala was performed using logistic regression, with
associations reported as odds ratios. Interactions among risk
factors of malaria during travel were explored, and none were
found to be statistically significant. Reasons why participants
traveled were not included in the final model analysis because
of collinearity of some reasons, for example, accompanying
parents or guardians with age categories. All comparisons
were considered statistically significant at P < 0.05.
RESULTS
Characteristics of study participants. From July through
August 2019, 186 cases and 524 controls were screened, and
162 cases and 405 controls were enrolled (Figure 1). All cases
and most controls were excluded because they resided out-
side of Kampala. Cases and controls were similar in age and
location of residence, but not gender (Table 1); more controls
than cases were female (62.7% versus 46.3%, P < 0.001).
Overall, 158 participants reported recent overnight travel, in-
cluding 128 (78.4%) cases and 31 (7.7%) controls.
Characteristics of participants who traveled. Of those
participants who traveled (Table 2), more cases than controls
were aged < 5 years (33.1% versus 9.7%, P < 0.001). Partic-
ipants made only one trip within 60 days and traveled to all
regions across the country, although they traveled to districts
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neighboring Kampala more frequently (Figure 2). For both
groups, the median duration of stay when traveling was
3 days. Compared with controls, cases were more likely to
have traveled to a district without an ongoing IRS program
(97.6% versus 67.7%, P < 0.001). Both cases and controls
commonly traveled to visit relatives and for funerals, but
controls were more likely to travel for work (19.4% versus
3.9%, P = 0.02). Travelers in both groups commonly stayed in
the homeof friends or relatives and engaged in similar evening
activities, although cases were more likely to sit outside in the
garden (23.6% versus 6.3%, P < 0.001). Controls were far
more likely than cases to have slept under an ITN while trav-
eling (64.5% versus 15.8%, P < 0.001).
Association between recent overnight travel outside
Kampala andmalaria. In an analysis adjusted for gender and
location of residence (Table 3), recent overnight travel was
strongly associated with malaria; participants who traveled
within the last 60 days had significantly higher odds of a
positive malaria test than those without recent travel (80.4%
versus 8.6%, adjusted odds ratio [aOR] 58.9, 95% CI:
23.1–150.1, P < 0.001). The odds of malaria was also higher in
males than in females (36.6%versus 22.8%, aOR2.0, 95%CI:
1.02–3.91, P = 0.04). No association between location of
residence and malaria was found (Table 3).
Factors associated with malaria among participants who
traveled. In an analysis restricted to participants who traveled,
older age, travel to a non-IRSdistrict, duration of travel for 10 days
or more, not using an ITN during travel, staying with friends and
relatives, and engaging in outdoor evening activities were all as-
sociatedwithmalaria (Table 4). Participantswho traveled to anon-
IRS district were at much higher odds of malaria than those who
traveled to a district covered by IRS (85.5% versus 23.1%, OR
35.0, 95%CI: 4.8–254.9, P < 0.001) as were participants who did
not use an ITN when traveling, compared with those who did
(90.7% versus 50.0%, OR 30.1, 95%CI: 6.4–142.7, P < 0.001).
DISCUSSION
Our findings fromamatchedcase–control study indicate that
travel out of Kampala was strongly associated with increased
FIGURE 1. Study profile.
TABLE 1
Characteristics of study participants
Characteristic Cases (positive malaria test) Controls (negative malaria test)
Total number of study participants (N = 567) 162 405
Mean age (SD), years 17.7 (16.3) 18.6 (17.3)
Age categories, n (%)
Below 5 years 56 (34.6) 140 (34.6)
5–15 years 26 (16.1) 65 (16.1)
16 years or older 80 (49.4) 200 (49.4)
Female gender, n (%) 75 (46.3) 254 (62.7)
Division of residence in Kampala, n (%)
Kampala central 11 (6.8) 37 (9.1)
Kawempe 15 (9.3) 21 (5.2)
Makindye 20 (12.4) 41 (10.1)
Nakawa 114 (70.4) 295 (72.8)
Rubaga 2 (1.2) 11 (2.7)
Participantswith history of overnight travel,n (%) 127 (78.4) 31 (7.7)
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odds of clinical malaria for Kampala residents presenting with
fever. Among travelers, failure to sleep under an ITN during
travel and travel to districts that had not received IRS were
strongly associatedwith increased risk ofmalaria. Other factors
associated with increased odds of malaria in travelers included
engaging in outdoor activities, age below 16 years, travel for
³ 10 days, and staying at a relative’s home. According to the
Uganda malaria indicator survey in 2018–2019, the proportion
of children under 5 years of age who tested positive for malaria
in Kampalawasmuch lower (0.2%bymicroscopy and 1.6%by
RDT) than in the rest of the country (9.1% by microscopy and
16.9% by RDT).28 These findings suggest that Kampala resi-
dents who are diagnosed with malaria are likely to have ac-
quired their infection because of recent overnight travel outside
of the city, and personal protection measures such as sleeping
under an ITNshouldbeemphasized topreventmalaria infection
during travel.
We found that many study participants (27.9%), all resi-
dents of Kampala presenting to Naguru General Hospital
with fever, had a history of recent overnight travel. Our
findings were consistent with a prior study conducted at
three sites of varied malaria transmission intensity in
Uganda, in which 23.3% of participants living in a peri-
urban setting had traveled out of their subcounty of resi-
dence, with a greater than 3-fold increase in the incidence
of malaria following overnight travel.21 Our findings are also
consistent with those from additional studies from other
African countries.19,29 A case–control study conducted in
urban and peri-urban Malawi suggested that overnight
travel increased the risk of malaria.19 Additional studies
conducted in Africa showed that returning residents, de-
fined as residents of a low-risk area returning from a trip
away, were at a high risk of malaria.14,18,30 In Zanzibar and
Bioko Island, parasites were introduced by returning resi-
dents, which frustrated malaria control efforts.14,18 Similarly, in
Swaziland and the regions of KwaZulu-Natal, Mpumalanga,
and Limpopo in South Africa, malaria parasites were reintro-
duced fromMozambique following implementation of intensive
malaria control.30,31 These findings from malaria-endemic
areas in Africa highlight that traveling between low and high
malaria transmission areas is common, and that returning res-
idents are at increased risk of malaria.
In study participants who traveled, we found that ITN use
was uncommon and strongly associated with an increased
risk of malaria. Previous studies have also suggested that
ITN use was reduced during overnight travel.21,32 Reasons
for infrequent use of ITNs included having no place to hang
the ITN, limited availability of ITNs, and social barriers, such
as fear of appearing disrespectful to others.32 As malaria
control interventions are scaled-up, it is important to en-
courage use of ITNs during travel to areas of high malaria
risk. Policy makers should also consider increasing ITN
availability so that those at risk, whether travelers or resi-
dents, are protected.
TABLE 2
Characteristics of participants with a history of recent overnight travel
Characteristic Cases (positive malaria test) Controls (negative malaria test)
Age categories, n (%)
Below 5 years 42 (33.1) 3 (9.7)
5–15 years 18 (14.2) 0
16 years or older 67 (52.8) 28 (90.3)
Female gender, n (%) 60 (47.2) 19 (61.3)
Duration of stay, median (IQR), d 3 (2–9) 3 (2–6)
Travel to non-IRS district*, n (%) 124 (97.6) 21 (67.7)
Time from first night of travel to
presentation with fever, median (IQR), day
22 (13–45) 24 (7–44)
Primary reason for overnight travel, n (%)
Visiting relatives 58 (45.7) 19 (61.3)
Accompanying parents 33 (26.0) 1 (3.2)
Funeral rite 18 (14.2) 3 (9.7)
Work 5 (3.9) 6 (19.4)
Attending school 5 (3.9) 0
Conference or workshop 5 (3.9) 0
Party or cultural gathering 3 (2.4) 2 (6.5)
Primary place for accommodation, n (%)
Friend’s or relative’s home 108 (85.0) 26 (83.9)
Camp 10 (7.9) 2 (6.5)
School 5 (3.9) 0
Hotel 2 (1.6) 3 (9.7)
Hospital 1 (0.8) 0
Church 1 (0.8) 0
Primary activity in the evening, n (%)
Went to bed right away 42 (33.1) 6 (19.4)
Watched TV/listened to the radio 36 (28.4) 17 (54.8)
Sat in the gardens 30 (23.6) 2 (6.3)
Stayed at work 9 (7.1) 0
Had a drink with friends 9 (7.1) 0
Helped with house chores 1 (0.8) 6 (19.4)
Went to bed after 9 PM, n (%) 84 (66.1) 25 (80.7)
Slept under insecticide-treated net, n (%) 20 (15.8) 20 (64.5)
IRS = indoor residual spraying.
* District that has not received IRS within 12 months before travel.
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We also found that, among travelers, engaging in outdoor
activities was strongly associated with increased risk of
malaria. Outdoor activities may increase exposure to mos-
quito bites and subsequent malaria,33–37 suggesting that use
of personal protectionmeasures to avoid outdoor exposure to
malaria vectors during travel, including mosquito repellent
creams and sprays, should be explored. Mosquito repellents
have been used primarily for malaria prevention by travelers
FIGURE 2. Map of Uganda showing destination of travel for study participants with a history of recent overnight travel out of Kampala. This figure
appears in color at www.ajtmh.org.
TABLE 3
Recent overnight travel out of Kampala and the risk of malaria
Risk factor Proportion testing positive for malaria, n/N (%)
Univariate analysis Multivariate analysis
OR (95% CI) P-value OR (95% CI) P-value
Gender
Female 75/329 (22.8) Reference Reference
Male 87/238 (36.6) 1.95 (1.33–2.87) 0.001 2.0 (1.02–3.91) 0.04
Place of residence within Kampala
Kampala central 11/48 (22.9) Reference Reference
Kawempe division 15/36 (41.7) 2.40 (0.94–6.15) 0.07 3.12 (0.64–15.2) 0.16
Makindye division 20/61 (32.8) 1.43 (0.61–3.38) 0.41 2.14 (0.47–9.81) 0.33
Nakawa division 114/409 (27.9) 1.23 (0.61–2.47) 0.57 1.59 (0.51–4.93) 0.42
Rubaga division 2/13 (15.4) 0.59 (0.11–3.06) 0.53 0.46 (0.03–6.26) 0.56
Recent overnight travel out of Kampala
No history of travel within 60 days 35/409 (8.6) Reference Reference
History of travel within 60 days 127/158 (80.4) 55.4 (22.6–135.8) < 0.001 58.9 (23.1–150.1) < 0.001
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from malaria non-endemic countries when traveling to
malaria-endemic areas.38,39 Commonly used repellents, in-
cluding N,N-diethyl-3-methylbenzamide, have good safety
profiles.40 When used properly, repellents can provide pro-
tection for up to 6 hours.41 However, studies evaluating mass
distribution of topical mosquito repellents have not shown an
impact on malaria parasite prevalence because of poor
compliance with daily use.42
Useof chemoprophylaxis, that is, regular administration of a
drug topreventmalaria infection is a keycomponent ofmalaria
prevention in travelers.43,44 Chemoprophylaxis is recom-
mended for travelers from malaria non-endemic countries to
malaria-endemic regions,22 but the same practice might be
beneficial for travelers to high transmission areas in Africa.
Standard recommendations for malaria chemoprophylaxis
are daily atovaquone–proguanil, daily doxycycline, or weekly
mefloquine; primaquine and tafenoquine are also effective but
require confirmation of normal glucose-6-phosphate de-
hydrogenase levels before use.43 Chemoprophylaxis should
be initiated shortly before the trip begins and continued for
1–4 weeks after completion of travel, depending on the drug
used.Aswith travelers fromnon-endemic countries, theuseof
chemoprophylaxis in addition to specific mosquito control
measures is likely to provide substantial protection against
malaria infection in travelers to high-risk areas of Africa.
Our study had some limitations. First, like all case–control
studies, the study was prone to selection bias which can lead
tomistaken inference.However, selection biaswasminimized
by selecting both cases andcontrols from the sameoutpatient
department and using the same diagnostic algorithm for both
groups. Second, we could not rule out recall bias concerning
travel histories, especially because history of travel was de-
fined over a 60-day period. It is possible that participants with
malariamight have beenmore likely to recall or report travel as
compared with those without malaria. Third, the case–control
study design only allowed assessment of the association
between overnight travel and malaria as odds ratios, and it
was not possible to estimate the actual risk of malaria among
travelers. Fourth, we did not capture data on behavioral or
household factors that might affect malaria risk at participant’s
homes. It is possible that participants with higher risk-
associated behaviors while traveling may practice those same
patterns while at home, although risks would nonetheless be
limited by the low malaria transmission intensity in Kampala.
Last, the studywas conducted over a period of 2months and in
only one hospital in Kampala, and results cannot be considered
representative of risks at other times of the year, or for other
locations.Nonetheless, theveryhighodds formalariaafter travel
strongly suggest that travel out of Kampala was responsible for
the majority of malaria diagnosed in this urban setting.
In summary, malaria among Kampala residents was
strongly associated with overnight travel, especially travel to
high-risk districts of Uganda that were not receiving IRS.
Among those who traveled, not using an ITN during travel,
engaging in outdoor activities, staying with friends and rela-
tives, and duration of travel for 10 days or more were associ-
atedwith increased odds ofmalaria. Our findings suggest that
personal malaria prevention measures, including use of ITNs,
application of creams or sprays to prevent outdoor mosquito
bites, and administration of chemoprophylaxis should be
emphasized toprotect individuals traveling overnight from low
to high transmission regions of Africa.
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